Cantor Fitzgerald’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.98M Buy
129,006
+41,354
+47% +$1.27M 0.04% 162
2026
Q2
$2.5M Sell
87,652
-73,676
-46% -$1.59M 0.03% 173
2026
Q1
$1.85M Sell
161,328
-85,490
-35% -$1.2M 0.03% 156
2025
Q4
$3.55M Buy
246,818
+121,674
+97% +$2.1M 0.05% 127
2025
Q3
$2.37M Buy
125,144
+2,637
+2% +$43.5K 0.02% 148
2025
Q2
$2.63M Buy
122,507
+107,861
+736% +$1.6M 0.05% 94
2025
Q1
$192K Buy
+14,646
New +$217K ﹤0.01% 218

Other funds holding OSCR

Cantor Fitzgerald's OSCR Position: Q3 2026 in Review

Cantor Fitzgerald increased its Oscar Health (OSCR) stake by 47% in Q3 2026, buying an estimated $1.27M and bringing the position to 129,006 shares worth $3.98M. The position accounts for 0.04% of the portfolio, ranked #162.

Cantor Fitzgerald first reported a position in OSCR in Q1 2025 and has held it in 7 quarters since. 423 funds tracked by Wall St. Rank hold OSCR as of Q3 2026.

  • Cantor Fitzgerald held 129,006 shares of Oscar Health worth $3.98M as of Q3 2026.
  • Cantor Fitzgerald bought 41,354 Oscar Health shares in Q3 2026, an estimated $1.27M.
  • Oscar Health made up 0.04% of Cantor Fitzgerald's portfolio in Q3 2026, its #162 holding.
  • Cantor Fitzgerald first reported a position in Oscar Health in Q1 2025 and has held it in 7 quarters since.
  • 423 funds tracked by Wall St. Rank held Oscar Health as of Q3 2026.

Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.